A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Intervention: Drug: Cannabidiol Oral Solution [Epidiolex] Sponsor: Jazz Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2023 Category: Research Source Type: clinical trials
Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex Interventions: Other: Rapamycin; Other: Placebo Sponsor: Katarzyna Kotulska Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2022 Category: Research Source Type: clinical trials